Logo image of SBS.DE

STRATEC SE (SBS.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SBS - DE000STRA555 - Common Stock

22.15 EUR
-0.3 (-1.34%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SBS. SBS was compared to 62 industry peers in the Health Care Equipment & Supplies industry. SBS has an average financial health and profitability rating. SBS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SBS had positive earnings in the past year.
SBS had a positive operating cash flow in the past year.
In the past 5 years SBS has always been profitable.
In the past 5 years SBS always reported a positive cash flow from operatings.
SBS.DE Yearly Net Income VS EBIT VS OCF VS FCFSBS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a Return On Assets value of 3.72%, SBS perfoms like the industry average, outperforming 49.23% of the companies in the same industry.
SBS has a Return On Equity (6.67%) which is comparable to the rest of the industry.
SBS has a Return On Invested Capital of 5.32%. This is comparable to the rest of the industry: SBS outperforms 44.62% of its industry peers.
SBS had an Average Return On Invested Capital over the past 3 years of 6.93%. This is below the industry average of 9.74%.
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROIC 5.32%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
SBS.DE Yearly ROA, ROE, ROICSBS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SBS has a Profit Margin of 6.22%. This is comparable to the rest of the industry: SBS outperforms 50.77% of its industry peers.
SBS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 10.94%, SBS perfoms like the industry average, outperforming 52.31% of the companies in the same industry.
SBS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 29.65%, SBS is doing worse than 86.15% of the companies in the same industry.
SBS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
SBS.DE Yearly Profit, Operating, Gross MarginsSBS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

SBS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SBS has about the same amount of shares outstanding.
The number of shares outstanding for SBS has been increased compared to 5 years ago.
Compared to 1 year ago, SBS has an improved debt to assets ratio.
SBS.DE Yearly Shares OutstandingSBS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SBS.DE Yearly Total Debt VS Total AssetsSBS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.73 indicates that SBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SBS has a Altman-Z score of 2.73. This is comparable to the rest of the industry: SBS outperforms 58.46% of its industry peers.
The Debt to FCF ratio of SBS is 41.27, which is on the high side as it means it would take SBS, 41.27 years of fcf income to pay off all of its debts.
SBS's Debt to FCF ratio of 41.27 is on the low side compared to the rest of the industry. SBS is outperformed by 61.54% of its industry peers.
SBS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SBS (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Altman-Z 2.73
ROIC/WACC0.82
WACC6.47%
SBS.DE Yearly LT Debt VS Equity VS FCFSBS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 4.19 indicates that SBS has no problem at all paying its short term obligations.
SBS has a Current ratio of 4.19. This is amongst the best in the industry. SBS outperforms 93.85% of its industry peers.
SBS has a Quick Ratio of 1.65. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
SBS has a better Quick ratio (1.65) than 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 4.19
Quick Ratio 1.65
SBS.DE Yearly Current Assets VS Current LiabilitesSBS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

SBS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.26%.
Measured over the past 5 years, SBS shows a small growth in Earnings Per Share. The EPS has been growing by 2.20% on average per year.
SBS shows a decrease in Revenue. In the last year, the revenue decreased by -4.73%.
SBS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.76% yearly.
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%

3.2 Future

The Earnings Per Share is expected to grow by 13.19% on average over the next years. This is quite good.
SBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.45% yearly.
EPS Next Y-10.4%
EPS Next 2Y10.58%
EPS Next 3Y12.99%
EPS Next 5Y13.19%
Revenue Next Year1.41%
Revenue Next 2Y4.05%
Revenue Next 3Y5%
Revenue Next 5Y7.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBS.DE Yearly Revenue VS EstimatesSBS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
SBS.DE Yearly EPS VS EstimatesSBS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.78, SBS is valued correctly.
87.69% of the companies in the same industry are more expensive than SBS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SBS to the average of the S&P500 Index (26.92), we can say SBS is valued slightly cheaper.
A Price/Forward Earnings ratio of 11.45 indicates a reasonable valuation of SBS.
86.15% of the companies in the same industry are more expensive than SBS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.46. SBS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.78
Fwd PE 11.45
SBS.DE Price Earnings VS Forward Price EarningsSBS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SBS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SBS is cheaper than 89.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 84.06
EV/EBITDA 8
SBS.DE Per share dataSBS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

SBS's earnings are expected to grow with 12.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)7.64
EPS Next 2Y10.58%
EPS Next 3Y12.99%

4

5. Dividend

5.1 Amount

SBS has a Yearly Dividend Yield of 2.71%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of SBS has falen by -21.59%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 1.11, SBS pays a better dividend. On top of this SBS pays more dividend than 87.69% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, SBS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.71%

5.2 History

The dividend of SBS decreases each year by -7.63%.
Dividend Growth(5Y)-7.63%
Div Incr Years0
Div Non Decr Years5
SBS.DE Yearly Dividends per shareSBS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

SBS pays out 45.53% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP45.53%
EPS Next 2Y10.58%
EPS Next 3Y12.99%
SBS.DE Yearly Income VS Free CF VS DividendSBS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
SBS.DE Dividend Payout.SBS.DE Dividend Payout, showing the Payout Ratio.SBS.DE Dividend Payout.PayoutRetained Earnings

STRATEC SE

FRA:SBS (12/23/2025, 7:00:00 PM)

22.15

-0.3 (-1.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2025-11-07
Earnings (Next)N/A N/A
Inst Owners37.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap269.34M
Revenue(TTM)257.62M
Net Income(TTM)16.02M
Analysts80
Price Target34.58 (56.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.71%
Yearly Dividend0.55
Dividend Growth(5Y)-7.63%
DP45.53%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-6.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.76%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 16.78
Fwd PE 11.45
P/S 1.05
P/FCF 84.06
P/OCF 12.33
P/B 1.12
P/tB 2.14
EV/EBITDA 8
EPS(TTM)1.32
EY5.96%
EPS(NY)1.93
Fwd EY8.74%
FCF(TTM)0.26
FCFY1.19%
OCF(TTM)1.8
OCFY8.11%
SpS21.19
BVpS19.74
TBVpS10.36
PEG (NY)N/A
PEG (5Y)7.64
Graham Number24.22
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROCE 7.38%
ROIC 5.32%
ROICexc 5.68%
ROICexgc 8.34%
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
FCFM 1.24%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
ROICexc(3y)7.69%
ROICexc(5y)10.12%
ROICexgc(3y)11.48%
ROICexgc(5y)16.01%
ROCE(3y)9.61%
ROCE(5y)11.28%
ROICexgc growth 3Y-26.1%
ROICexgc growth 5Y2.82%
ROICexc growth 3Y-25.31%
ROICexc growth 5Y3.93%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Debt/EBITDA 2.49
Cap/Depr 99.05%
Cap/Sales 7.24%
Interest Coverage 5.44
Cash Conversion 46.48%
Profit Quality 20%
Current Ratio 4.19
Quick Ratio 1.65
Altman-Z 2.73
F-Score7
WACC6.47%
ROIC/WACC0.82
Cap/Depr(3y)101.4%
Cap/Depr(5y)105.66%
Cap/Sales(3y)6.8%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
EPS Next Y-10.4%
EPS Next 2Y10.58%
EPS Next 3Y12.99%
EPS Next 5Y13.19%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%
Revenue Next Year1.41%
Revenue Next 2Y4.05%
Revenue Next 3Y5%
Revenue Next 5Y7.45%
EBIT growth 1Y-3.3%
EBIT growth 3Y-17.64%
EBIT growth 5Y9.13%
EBIT Next Year47.63%
EBIT Next 3Y26.73%
EBIT Next 5Y15.67%
FCF growth 1Y114.46%
FCF growth 3Y-10.96%
FCF growth 5YN/A
OCF growth 1Y1784.43%
OCF growth 3Y-8.44%
OCF growth 5Y18.03%

STRATEC SE / SBS.DE FAQ

Can you provide the ChartMill fundamental rating for STRATEC SE?

ChartMill assigns a fundamental rating of 4 / 10 to SBS.DE.


What is the valuation status of STRATEC SE (SBS.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to STRATEC SE (SBS.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for STRATEC SE?

STRATEC SE (SBS.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of STRATEC SE (SBS.DE) stock?

The Price/Earnings (PE) ratio for STRATEC SE (SBS.DE) is 16.78 and the Price/Book (PB) ratio is 1.12.


What is the expected EPS growth for STRATEC SE (SBS.DE) stock?

The Earnings per Share (EPS) of STRATEC SE (SBS.DE) is expected to decline by -10.4% in the next year.